The First Lung Cancer Vaccine Enters Clinical Trial Phase in Seven Countries
Lung cancer is one of the leading causes of mortality worldwide, with an estimated 1.8 million deaths annually, according to the World Health Organization (WHO). Currently, the development of an effective vaccine against this type of cancer is considered one of the greatest advancements in oncology.
Recently, the first messenger RNA (mRNA) vaccine for lung cancer has entered clinical trials, generating significant anticipation in the scientific and medical communities. This article explores the details of this breakthrough, the scope of the trials, and future perspectives in the treatment of this disease.
Background of the Research
CONTINUE READING ON THE NEXT PAGE 🥰💕